Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.
Show more...
FAQ
Revelation Biosciences 今天的股價是多少?▼
REVB 目前價格為 $1.18 USD,過去 24 小時上漲了 +4.42%。在圖表上更密切關注 Revelation Biosciences 股價表現。
Revelation Biosciences 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Revelation Biosciences 的股票以代號 REVB 進行交易。
Revelation Biosciences 的股價在上漲嗎?▼
REVB 股票較上週上漲 +18%,本月上漲 +20.41%,但過去一年 Revelation Biosciences 下跌 -90%。
Revelation Biosciences 的市值是多少?▼
今天 Revelation Biosciences 的市值為 4.61M
Revelation Biosciences 下一次財報日期是什麼時候?▼
Revelation Biosciences 將於 August 07, 2026 公布下一次財報。
Revelation Biosciences 上一季度的財報如何?▼
REVB 上一季度的財報為每股 -2.71 USD,預估為 -2.71 USD,帶來 +0% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Revelation Biosciences 去年的營收是多少?▼
Revelation Biosciences 去年的營收為 0USD。
Revelation Biosciences 去年的淨利是多少?▼
REVB 去年的淨收益為 -15.04MUSD。
Revelation Biosciences 有多少名員工?▼
截至 July 18, 2026,公司共有 8 名員工。
Revelation Biosciences 位於哪個產業?▼
Revelation Biosciences從事於Health & Wellness產業。
Revelation Biosciences 何時完成拆股?▼
Revelation Biosciences 上次拆股發生於 January 28, 2026,比例為 1:4。
Revelation Biosciences 的總部在哪裡?▼
Revelation Biosciences 的總部位於 美國 的 San Diego。